Summary: Antiviral therapy of human immundeficiency virus (HIV) infection is currently based on Inhibition of reverse transcriptase by dideoxynucleosides, such äs azidothymidine. Because of widespread toxicity it is reasonable to selectively target these drugs to infected cells. This may be accomplished utilizing drug-LDL conjugates, which are interüalized via cell specific receptor pathways. With respect to HIV infection, scavenger receptors of the macrophage System seems to offer a hopefull perspective. This pathway requires chemical modification of surface polarity of the LDL. Cell experiments were conducted in HepG2 hepatocytes, which express apolipoprotein B receptors, and in P 388 macrophages, which express scavenger receptors. LDL particles to be conjugated were isolated from blood donor plasma and from LDL-apheresis waste material. Noncovalent LDL conjugation with amphiphilic nucleoside derivatives produced only an unspecific nucleoside transfer to cell membranes, due to instability of the LDL conjugates. An experimental method (coincubation test) was developed to identify those conjugates that are stable in the presence of other lipophilic compartments. Covalent coupling pf nuclepsides to the apolipoprotein B moiety of LDL particles resulted in stable conjugates. As a consequence, the surfaee Charge became negative, and the LDL displayed scavenger receptor affmity rather than apolipoprotein B receptor affinity. Selective targeting of nucleosides to macrophages can be accomplished by covalent coupling to LDL.
Introduction
. , -. -. . . , * · *u r it has been shown that ennchment via the apolipoThe concept of drug targeting dätes back to the in-protein B receptor pathway is insigniflcant (8 -10) . genious ideas Paul Ehrlich (1) . Since the recpgtiitiön e<J ^ a , so an attractive of receptor-mediated LDL^uptake m tumour oblb tion for the tieatamt of viral diseases . These diseases (2^6), drug targeting of cytotox,c agents v,a LDL 1 )
be treated effectiyd b antimetaboütes, such äs has been envisiged äs a means of impröving the 3zidoth^dine (15 16)) which cause tennination of chemotherapy of neoplastic diseases (7) . Howeyer, DNA chain el tipn in the infected cell> and are despite many efforts, no pracUcable regime of cell-therefore ^ tQ curtaij ^ m Qf myl HQW _ selective dehvery of a LDL-drug-conjugate has so far ^ tojd tQ ^ h oetic and neura , been developecL This is maanly due to the failure to , tem has hindered long . term high dose re g imes with obtam stable LDL-drug-conjugates (8, 9) . Moreover^ j."_' agents infection (11 -15) . This cell family possesses scavenger receptors, in contrast to the ubiquitous LDL apolipoprotein B receptor that are found, e. g. on blood monocytes, B and T lymphocytes and hepatocytes (17, 18) . Thus, utilization of the scavenger receptor pathway may avoid drug delivery to sensitive albeit non-infected cells. Drug delivery via this receptor has not been previously suggested. Linkage of azidothymidine or antisense oligonucleotides to LDL, in a way that favoured selective scavenger receptor uptake by macrophages, would offer a new route for antiviral chemotherapy.
The aim of our work was to obtain stable nucleoside/ LDL conjugates, which will be taken up selectively by the scavenger receptor of macrophages. It was intended to prepare stable nucleoside-LDL conjugates and to modify these conjugates in order to utilize scavenger receptor transport. Electrophoresis SDS-PAGE was performed according to the method of Cardin et al. (22) modified äs previously described (23) . Agarose lipoprotein electrophoresis was conducted with the Paragon Lipo Kit (Fa. Beckman).
Materials and Methods

Compounds
Chemical analysis
Total cholesterol was determined using the cholesteroloxidase/ 4-aminophenazone method, Monotest (Boehringer Mannheim, Germany); protein was determined according to Lowry et al. (24) .
Isolation of LDL particles LDL was isolated from citrated plasma of blood donors (courtesy Dr. Eckstein), and from membrane differential filtration apheresis (20) . LDL (fraction d = 1.019-1.063 kg/l) and lipoprotein-deficient serum (d > 1.21 kg/l) were prepared by sequential ultracentrifugation (21) . LDL fractions were dialysed 36h against Standard buffer (0.15 mol/1 NaCl, 0.5 mmol/1 EDTA, pH 7.4, 4 °C). Defibrination of lipoprotein-deficient serum was performed by incubation with thrombin (20 · l O 3 NIH U/l) at 24 °C for 10 min, and centrifugation at 30000g for 90 min. The purified fractions were sterile filtered over 0. 22 Millex filter (Millipore Co.) and stored at 4 °C. lodination of LDL LDL was 125 I-labeDed by the IC1 method of Karlin et al. (25) , purified over Sephadex G75 columns (20 l cm) and dialysed against Standard buffer. The trichloroacetic acid precipitates contained 97 -99% of the radioactivity. The specific activity was 200 -600 counts/min per ng protein.
Acetylation of LDL
LDL apheresis-derived material was acetylated by the method of Basu et al. (26) and dialysed for 36 h at 4 °C against Standard buffer. Occasionally turbidity was removed by centrifugation (12000g, 20 min). Sterile filtration was conducted äs äbove.
Cell transport tests
Human hepatocytes (HepG2, American tissue culture collection) were used. These cells were routinely screefied for mycoplasmä infection. Culturing was performed with Eagles minimum essential mediurn containing fetal calf serum, volüme fraction 0.1, at 37 °C and 5% CO 2 . For transport experirnents the cells were trypsinised (0.5 g/l trypsin, 0.5 g/l EDTA) and transferred into dishes (60 15 mm). On day four, the culture medium was replaced by lipoprotein-deficient serum, volüme fraction 0.1, containing medium for 12 to 18 h. The cell protein concentration at this time was 1-2 mg/dish. Binding, incorp oration and degradation was determined according to GoldStein & Brown (27) .
Murine macrophages (P 38 8, American tissme culture collection) were cultured in RPMI raedium with addition of non-essential amino acids and fetal calf serum, volüme fraction 0.1. For transport tests, the cells were suspended and transferred into dishes (35 15 mm). When sürviving cells became adherent (l h), medium was exehanged. LDL uptake was determined by quantification of intracellülar cholesterol ester using an HPTLC method (28) .
Conjugation of amphiphilic nucleoside derivatives to LDL
The conjugation was a modification of a method of Havekes et al. (29) . The incubation mixture contained 2.5 g LDL (protein) per litre final volüme (Standard buffer) and lipoproteindeficient serum, volüme fraction 0.25. The nucleoside derivatives were added äs methanolic Solutions (acyl-derivatives: 2 g/1; trityl-derivatives: 10 g/l) and incübated for 24 h at 37 °C Reisolation of LDL was performed by ultracentrifugation after addition of KBr (125 g/l) at 250 000 g for 22 h. LDL conjugates float, whereas free amphiphilie nucleoside derivatives are pelleted.
Quantification of nucleoside binding to LDL
The binding of 3 H-labelled nucleosides to LDL was determined by calculation of specific activity per mg of LDL-protein. An aliquot (0.5 ml) of LDL nucleoside conjugate or acetyl-LDL nucleoside conjugate (approx. 500 g protein) was lyophilised and extracted with l ml methanol for 24 h at room temperature. After centrifugation, the nucleoside extract was subjected to HPLC on RP 18. The eluent was acetate buffer (pH 7.2, 50 mmol/l)/methanol in the proportion 15/85, by volüme, for trityl-azidothyrnidine and 5/95, by volüme for acyl-azidothymidine. Detection was at UV 265 nm.
Stability tests
Heparin precipitation
An aliquot (0.5 ml) of LDL-nucleoside conjugate was mixed with 0.5 ml acetate buffer (pH 4.6; 100 mmol/1 Na-acetate, 200 mmol/I NaCl), incübated with 500 IÜ heparin (25 ) for 15 min at room temperature, then centrifuged (15 min, 12000g). The supernatant was discarded; the pellet was extracted with raethanol (1.0 ml). Further processing was peffofmed äs described above by HPLC or formed for acetylated LDL using citric acid (pH 2.2; 100 mmol/1) for incubation with heparin.
Dialysis
The LDL conjugates were dialysed at 37 °C against Standard buffer s indicated. Bo nd nucleoside derivatives were quantified by 3 H-labelling or HPLC.
Equilibrium dialysis
LDL nucleoside conjugate solution (200 μΐ) dialysed against the same volume of buffer s indicated for 24 h at 37 °C. The nucleoside redistribution on both sides of the dialysis membrane was determined by quantification of the bound fraction s above. 
Sephadex gel chromatography
Results
At first, we studied the stability of LDL conjugates, which were prepared by equilibrium techniques, using conventional stability tests. LDL and acetylated LDL were conjugated with lipophilised nucleosides (trityl-, O-stearoyl-azidothymidine, [ dialysis (85-94% binding after 34 h at 37 °C). Equilibrium dialysis against several media (tab. 1) revealed high stability (> 97% binding after 20 h at 37 °C).
Reisolation of LDL (d = 1.019-1.063 kg/l) after Substrate conjugation in the presence of lipoproteindeficient serum, volume fraction 0.25, by ultracentrifugation results in 95% binding of the initial amount of nucleoside derivative to LDL ( fig. 2) . Gel chromatography of the LDL-nucleoside conjugate demonstrated > 70% binding to the eluted LDL. In summary, stability tests were satisfactory with acyl-nucleoside/LDL conjugates prepared by equilibrium methods (tab. 2).
Biological integrity of the LDL conjugates was demonstrated by electrophoretie mobility with SDS-PAGE and agarose electrophoresis and by celi transport studies with human hepatocytes (Hep G2) and murine macrophages (P 3 88>. The experiments showed that conjugation of LDL with amphiphilic nugleoside derivatives via solution equilibrium neither changed electrophoretie mobility, nor modified receptor affinity.
Receptor-mediated ligand internalization of LDLconjugates was determined by Because the results of the conventional stability tests did not agree with the results of the cell experiments, a new method for testing stability, referred to äs the "coincubation test", was developed (30) .
The principle of this test is precipitation of LDL with heparin at a certain pH after coincubation with acetyl-LDL, which does not precipitate at this pH. This precipitation is independent of drug conjugation. During coincubation of labelled LDL conjugates and acetyl-LDL (potential conjugate acceptor) a switch of the ligand can be detected. Because ligand donor (LDL conjugates) and ligand acceptor (acetyl-LDL) are equimolar with respect to LDL-cholesterol, the maximum redistribution of initial ligand radioactivity is 50%. The redistribution of [ The above results show, that conjugation via solution equilibrium is not an appropriate method for obtaining stable LDL conjugates. Hence, the method of covalent ligand coupling was employed using 4-nitrophenyl-thymidine-ester (19) . Thymidine coupling to' LDL (19) is limited by protein denaturation, which occurs at a 4-nitrophenyl-thymidine-ester concentration of 10 g/l ( fig. 6 ). The maximal loading of thy- midine is 300 thymidine molecules per molecule apolipoprotein B. Hence, 88% of the 338 lysyl residues (38) were coupled. The reaction results in the'formation of an ainide bond. This implies that the coupled lysyl residues lose their basic property. Consequently, the surface Charge of LDL-apolipoprotein B correlates with the thymidylation rate, which is dem* onstrated by agarose lipoprotein electrophoresis ( fig. 7) .
Stability of the thymidine-LDL complex has already been demonstrated by agarose eleetrophoresis. Further evidence of stability is provided by trichloroacetic acid precipitation: 97-99%* of the initial activity Figure 9 shows the results of transport experiments with unlabelled LDL particles and macrophages (P 388 ). Plasma-derived LDL particles were not taken up by the macrophages, äs indicated by the constancy of the intracellular cholesteryl ester content. On the other band, acetyl-LDL and thymidine-LDL were internalised to the same extent, äs shown by the increase of intracellular cholesteryl ester.
Discussion
A variety of conjugation methods for different LDL compartments has been published, employing several compounds and drugs (8, 9, 31, 36 -39) . However, nucleosides have not previously been considered äs ligands. The aim of this study was to prepare nucleoside-LDL-conjugates, which can be transported selectively into HIV infected cells via LDL receptor pathways.
The results show that amphiphilic nucleoside derivatives conjugated with LDL are not suited for cellselective transport via either of the two LDL receptor pathways, despite the fact that these conjugates show adequate stability in conventional stability tests.
An explanation of this unexpected finding is provided by the results of a new type of experiment, which is referred to äs the "coincubation test". In this test instability of the LDL conjugates was demonstrated in the presence of another lipophilic solution compartment (acetyl-LDL). Thus, unspecific uptake is likely to avoid receptor pathways and a direct tränsfer of the ligand to the cell membrane may occur. Conventional stability tests in pure aqueous media do not a priori reveal these phenomena, despite the fact that unstable conjugates, such äs trityl-azidothymidine/ LDL show their character. One may remember, that in equilibrium dialysis direct contact between both lipoprotein Solutions is prevented by the dialysis membrane. Thus, only stability in aqueous Solutions and not in a heterogeneous System can be demonstrated by the conventional methods.
The results help to Interpret some, äs yet not fully understood, findings reported in the literature concerning LDL conjugates:
-Iwanik (31) demonstrated, that a substantial amount of daunomycine (16%) was found in the plasma membrane in P 38 8 cells, when offered äs LDL conjugate, whereas free daunomycine is found to 2% in the plasma membrane. This fact may be explained by direct ligand shift from LDL to the plasma membrane.
-Rudling's (9) experiments indicated a small specific uptake of aclacinomycine A in tumour cells (U-251 MG), when offered äs LDL conjugates. Hence, a large fraction of the observed total transport must have been unspecific.
-Vitols (8) demonstrated a major unspecific uptake of anthracycline into white blood cells. In these experiments LDL conjugates were prepared by Krieger's reconstitution method. Hence, the assumed stability was probably only partially maintained.
-Schöneshöfer (32) demonstrated, that probucol in plasma is bound to LDL; its half-life is more than 60 days, hence direct transfer to LDL particles with a half-life of 2 days should have occurred.
Within this frame of reference, the following additional important fact should be considered. Ever since the classical work of Goldstein & Brown (27) , it is common practice to demonstrate specificity of LE)L iiiternalization via the apolipoprotein B receptor pathway by adding unlabelled LDL äs a competitive inhibitor. When this technique is applied to transport experiments with LDL conjugates, an extensive reduction of ligand uptake is observed. The conclusion however, that this phenomenon is due to displacement of the LDL conjugate from the receptor, may be wrong. If, for instance, the addition of albumin causes a similar reduction, the mechanism must be unspecific. Redistribution of the LDL ligand to now available lipophilic compartments (LDL-excess, bovine serum albumin) takes place, äs demonstrated by working up the incubation media with ultracentrifugation. In conclusion, competition experiments with LDL äs the competitor are acceptable only when the LDL conjugate is shown to be stable in the coincubation test.
Since the acyl-nucleoside/LDL conjugates exhibited instability, covalent coupling of nucleosides to the protein moiety of the LDL particle was developed. Thymidine was used äs a representative compound for dideoxynucleosides. The same coupling reaction can be applied to any type of nucleoside.
The increased covalent binding of thymidine leads to the loss of surface cationicity, and thereby to the loss of apolipoprotein B receptor affinity. Scavenger receptor affinity is implemented instead. This became evident in cell transport experiments, in which competitive Inhibition was used äs an indicator of receptor-mediated internalization: the uptake of native 125 Ilabelled LDL into HepG2 cells could not be abolished by thymidine-LDL. On the other hand, in inacrophages (PassX thymidine-LÜL was transported in the same way äs acetyl-LDL, äs indicated by the same degree of enrichment of intracellular cholesteryl esters.
With respect to the type and degree of revealed surface modification, agarose electrophoresis and the resülts of cell transport experiments are in close agreement. One may remember, that many other modifications (derivatization with methyl-, glucosyl-, malondialdehyde-and hexandione-ligands (33, 18) ), which mask lysyl side chains, lead to the same transport behaviour.
The reported experiments indicate that therapeutic nucleosides can be selectively targeted to macrophages. The enrichment of 10 g cholesteryl ester per mg cell protein (P 388 -macrqphages) is equivalent to the establishment of 600 /1 nucleoside in the cytosol. Total Inhibition of feverse transcriptase^) in human macröphages occurs at 10 / azidothymidine (34).
However, a prerequisite for phannacological action of dideoxynucleoside-LDL-cömplexesis the release of the drug through lysosomal degradation. This remains to be demonstrated by in vitro reverse transcriptase Inhibition in infected macröphages.
It is known that macrophages have only a löw potential for phosphorylating nucleosides, which is a condition for the therapeutic action of nucleoside analogues (35) . But it is the ratio of azidothymidinetriphosphate to thymidine-triphosphate and not the absolute concentrations of these two compounds that is responsible for the reverse transcriptase Inhibition effect (34) . Thus, the low thymidine kinase activity does not necessarily contradict the proposal to treat macrophages with dideoxynucleosides.
Further experiments are needed to demonstrate whether, in cell cultures of Hl V4nfected human macrophages, these nucleoside LDL complexes cäri specifically inhibit HIV replication, A more general consideration of this therapeutic proposal would then be reasonable. 2 ) Enzyme: Reverse transcriptase, RNA-directed DNA polymeräse (EC 2.7.7.49).
